Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451171) titled 'Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: University of Virginia

Condition: Small Intestine Bacterial Overgrowth

Intervention: Drug: Trimethoprim-sulfamethoxazole (TMP/SMX) Drug: Metronidazole

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 2026

Target Sample Size: 60

Countries of Recruitment: Bangladesh

To know...